VC-backed Symphogen names new board director
Symphogen, a Copenhagen-based biopharmaceutical company, has named Annika Espander Jansson as a non-executive director of the board. The appointment was effective December 19, 2013. Jansson is currently the founder and CEO of Asperia. Symphogen's backers include Novo, Essex Woodlands Health Ventures and PKA.
20 December 2013•3 mins read
